MEEDER ASSET MANAGEMENT INC

Position in ENTA — Enanta Pharmaceuticals Inc

CIK 809443 DUBLIN, OH

Position in ENTA

as of Mar 31, 2026 · filed May 7, 2026 Compact

Position Value

$25,575

-$6,359 QoQ

Shares Held

2,025

0.0% QoQ

Ownership

0.007%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2020

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

MEEDER ASSET MANAGEMENT INC holds $7,091,404 across 37 Biotechnology names. ENTA ranks #8 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	6,094	$4,708,465
2	VRTX	Vertex Pharmaceuticals Inc / Ma	3,424	$1,528,950
3	CPRX	Catalyst Pharmaceuticals, Inc.	10,392	$257,305
4	BMRN	Biomarin Pharmaceutical Inc	1,838	$103,828
5	ADMA	Adma Biologics, Inc.	9,759	$87,928
6	VCEL	Vericel Corp	1,900	$61,123
7	MNPR	Monopar Therapeutics	637	$34,901
8	ENTA	Enanta Pharmaceuticals Inc This page	2,025	$25,575

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$25,575	2,025	0.0%	Shares	Sole	2026-05-07
2025-12-31	$31,934	2,025	+2150.0%	Shares	Sole	2026-02-11
2022-09-30	$4,668	90	-18.9%	Shares	Defined	2022-11-14
2022-06-30	$5,246	111	-16.5%	Shares	Defined	2022-08-08
2022-03-31	$9,466	133	+25.5%	Shares	Defined	2022-05-10
2021-09-30	$6,021	106	+11.6%	Shares	Defined	2021-11-08
2021-06-30	$4,180	95	-29.6%	Shares	Defined	2021-08-09
2021-03-31	$6,658	135	-6.2%	Shares	Defined	2021-04-28
2020-12-31	$6,062	144	+4.3%	Shares	Defined	2021-02-09
2020-09-30	$6,317	138	+360.0%	Shares	Defined	2020-11-02
2020-06-30	$1,506	30	—	Shares	Defined	2020-08-11
No filing history on record for this holder in this stock.